Tag: Dr Reddy’s

MUMBAI: Sun Pharma said on Thursday it is gearing up to introduce antiviral Covid-19 drug, molnupiravir under the brand Molxvir at "an economical price'' in India....

New Delhi: The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V C-19 vaccine for...

The government said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity...

The Drug Control General of India (DCGI) is soon going to remove the ‘trial mode’ tag for Bharat Biotech’s Covaxin C-19 vaccine...

Dr Reddy’s Laboratories has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the...

India will produce about 300 million doses of Russia’s Sputnik V C-19 virus vaccines next year, a Russian official was quoted as...

Hyderabad: Indian generic drug maker Dr Reddy’s Laboratories announced entering into a non-exclusive licensing agreement with Gilead Sciences, which grants the Indian firm...

Dr. Reddy's receives EIR from USFDA Dr Reddy's Laboratories Ltd has received the Establishment Inspection Report (EIR) from US...

Dr Reddy’s recalls its heart burn medicine in US Dr Reddy’s Laboratories is recalling 1,752 bottles of generic heartburn...

New Delhi: The US health regulator has asked drug major Dr Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra Pradesh.

Dr. Reddy's Laboratories Ltd announced the launch of the US Food and Drug Administration (FDA) approved trientine hydrochloride capsules USP, 250 mg,...